Current neurotransmitter strategies in AD drug development

被引:0
|
作者
Francis, PT [1 ]
Alder, JT [1 ]
Cole, KL [1 ]
Heslop, KE [1 ]
Minger, SL [1 ]
Ramirez, MJ [1 ]
机构
[1] United Med & Dent Sch, Guys & St Thomas Hosp, Dementia Res Lab, Div Biochem & Mol Biol, London, England
关键词
D O I
暂无
中图分类号
B84 [心理学]; C [社会科学总论]; Q98 [人类学];
学科分类号
03 ; 0303 ; 030303 ; 04 ; 0402 ;
摘要
引用
收藏
页码:851 / 859
页数:9
相关论文
共 50 条
  • [21] FDA Guidance on Drug Development for Early AD
    不详
    JOURNAL OF NUCLEAR MEDICINE, 2018, 59 (04) : 14N - 14N
  • [22] Dealing with schistosomiasis: Current drug discovery strategies
    Gemma, Sandra
    Federico, Stefano
    Brogi, Simone
    Brindisi, Margherita
    Butini, Stefania
    Campiani, Giuseppe
    MEDICINAL CHEMISTRY APPROACHES TO MALARIA AND OTHER TROPICAL DISEASES, 2019, 53 : 107 - 138
  • [23] Current strategies for drug delivery to the inner ear
    Liu, Hongzhuo
    Hao, Jinsong
    Li, Kevin S.
    ACTA PHARMACEUTICA SINICA B, 2013, 3 (02) : 86 - 96
  • [24] Current Strategies and Applications for Precision Drug Design
    Wang, Chen
    Xu, Pan
    Zhang, Luyu
    Huang, Jing
    Zhu, Kongkai
    Luo, Cheng
    FRONTIERS IN PHARMACOLOGY, 2018, 9
  • [25] Current drug strategies for the treatment and control of schistosomiasis
    Villamizar-Monsalve, Maria Alejandra
    Lopez-Aban, Julio
    Vicente, Belen
    Pelaez, Rafael
    Muro, Antonio
    EXPERT OPINION ON PHARMACOTHERAPY, 2024, 25 (04) : 409 - 420
  • [26] Microglial Drug Targets in AD: Opportunities and Challenges in Drug Discovery and Development
    Biber, Knut
    Bhattacharya, Anindya
    Campbell, Brian M.
    Piro, Justin R.
    Rohe, Michael
    Staal, Roland G. W.
    Talanian, Robert V.
    Moller, Thomas
    FRONTIERS IN PHARMACOLOGY, 2019, 10
  • [27] Current Status and Research Strategies in Tuberculosis Drug Development (vol 54, pg 6157, 2011)
    Dover, Lynn G.
    Coxon, Geoffrey D.
    JOURNAL OF MEDICINAL CHEMISTRY, 2011, 54 (23) : 8233 - 8233
  • [28] Drug development in treatment-resistant depression: Current progress, major hurdles and future strategies
    Zarate, C.
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2014, 17 : 18 - 18
  • [29] TRANSLATIONAL STRATEGIES FOR RESPIRATORY DRUG DEVELOPMENT
    Ward, Christine K.
    INFLAMMATION RESEARCH, 2010, 59 : S277 - S277
  • [30] Bioanalytical strategies in drug discovery and development
    Thakur, Aarzoo
    Tan, Zhiyuan
    Kameyama, Tsubasa
    El-Khateeb, Eman
    Nagpal, Shakti
    Malone, Stephanie
    Jamwal, Rohitash
    Nwabufo, Chukwunonso K.
    DRUG METABOLISM REVIEWS, 2021, 53 (03) : 434 - 458